What do we need to know about active ingredients? - PowerPoint PPT Presentation

1 / 9
About This Presentation
Title:

What do we need to know about active ingredients?

Description:

... nutritional and pharmacological approaches applicable to herbal supplements? ... Identification of meaningful components should precede study of their ... – PowerPoint PPT presentation

Number of Views:34
Avg rating:3.0/5.0
Slides: 10
Provided by: fox85
Learn more at: http://www.lsro.org
Category:

less

Transcript and Presenter's Notes

Title: What do we need to know about active ingredients?


1
What do we need to know about active ingredients?
  • Workshop 1

2
Discussion focus--Botanicals
  • Question
  • Are traditional nutritional and pharmacological
    approaches applicable to herbal supplements?
  • Multiple biologically active substances in
    products
  • Multiple biological activity endpoints

3
Identifying meaningful components
  • Meaningful Components that produce a biological
    effect
  • Identification of meaningful components should
    precede study of their bioavailability
  • Analytical chemistry databases inadequate for
    botanicals

4
Analytical database development
  • NAPRALERT, IBIDSgood sources, need to expand
    knowledge base internationally
  • USDA databases as models

5
Reference materials
  • Standardized products needed for research
  • Dietary fiber fish oil standard products as
    models
  • Industry should collaboratively
    developnonproprietary, best first guess as to
    efficacy/safety
  • USP certification

6
Clinical trials
  • Need standard reference products
  • Use classical approach (Phase I, II, etc..)
  • Determine priorities for clinical trials
  • Selection criteria?
  • Extent of use
  • Efficacytarget major public health issues
  • Safety

7
Bioassays
  • potential screening tools
  • use with caution
  • No substitute for clinical studies

8
Biomarkers
  • Little progress to date
  • May be useful

9
Summary
  • Identification of meaningful (bioactive)
    components should be the main focus
  • Bioavailability may be a key determinant of
    bioactivity
  • Need for standard reference materials
  • Clinical studies should be based on these 3
    research areas
Write a Comment
User Comments (0)
About PowerShow.com